- Lilly concluded its first digital health open innovation challenge, “Transforming IBD Care: Better Disease Monitoring, Management, and Care for People with Inflammatory Bowel Disease,” and selected HealthVoyager as the winner.- The challenge culminated in a competition hosted at Lilly’s headquarters in Indianapolis, where five finalists presented their digital health solutions aimed at transforming IBD care to a panel of judges.Eli Lilly and Company, today announced it has named HealthVoyager,
Read More
Eli Lilly
Lilly Launches Innovation Challenge to Transform IBD Care Through Digital Health
Eli Lilly and Company (NYSE: LLY) is launching an open innovation challenge to encourage individuals and teams across the U.S. to identify and submit pioneering digital health solutions aimed at transforming inflammatory bowel disease (IBD) care. The challenge, "Transforming IBD Care: Better disease monitoring, management, and care for people with inflammatory bowel disease" focuses on innovation in IBD monitoring, condition management or care enhancements.Impact of Inflammatory Bowel Disease
Read More
Research: Apple Devices Could Detect Early Alzheimer’s Disease (AD) Dementia
Eli Lilly, Evidation Health, and Apple has released initial results from a feasibility study that reveals an iPhone, Apple Watch, iPad, and the Beddit sleep monitoring device, in combination with digital apps, may be able to differentiate people with mild cognitive impairment (MCI) and mild Alzheimer's disease dementia. The exploratory results were presented today at the Association for Computing Machinery's KDD conference in Anchorage, and are published on the conference website.Impact of
Read More
Research: Livongo for Diabetes Program Improved Diabetes Distress Levels
Livongo, an Applied Health Signals company empowering people with chronic conditions to live better and healthier lives, today announced the findings of a study conducted in collaboration with Eli Lilly and Company that demonstrated 94 percent of Livongo program Members who participated in a program survey achieved improved Diabetes Empowerment Scale-Short Form (DES-SF) or Diabetes Distress Scale 2 (DDS2) in year one. The research findings were presented on June 8, 2019, at the American Diabetes
Read More
You Want Patient Engagement? Make The System Navigable
Last month, New York Times reporter Robert Pear died at age 69 from complications of a stroke. The name was unfamiliar to me, and I guess that’s to be expected, given what I’ve learned of the man since.
Turns out Robert Pear was a thoughtful, unassuming reporter who wanted the accuracy and validity of his work to speak for him. This approach engendered much respect among his peers in the 40 years that he primarily covered healthcare policy.
“Robert was an exacting reporter,” writes
Read More
Livongo for Diabetes Program Reduced Medical Spending by 22% for Members, Study Finds
The Livongo for Diabetes program delivered a 21.9 percent reduction in medical spending for Livongo members when compared to the matched non-Livongo population, according to study findings published in the latest edition of the Journal of Medical Economics. When taking the average price of the Livongo for Diabetes program into account, the study demonstrated that employers experienced a positive return on investment in one year.Financial Impact of Diabetes Management in the U.S.Diabetes is one
Read More
Eli Lilly Offers Designers $75k to Redesign Clinical Trial Info for Patients
Eli Lilly opens Clinical Trial Visualization Redesign Challenge for designers & developers to make clinical trial information more patient-friendly.
Read More
